BridgeBio Oncology Therapeutics (BBOT) Technical Analysis

As of 2026-07-22, BBOT last traded at 8.9 USD (+2.06% on the day) and is in a range on the daily timeframe — moving averages not aligned / flat. Nearest levels: 8.535 USD support below, 9.247 USD resistance above. 14-day RSI is 63.2 (bullish).

Last updated 2026-07-22 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ

Is BBOT in an uptrend or downtrend?

BridgeBio Oncology Therapeutics is in a range — moving averages not aligned / flat.

Last close8.9 USD (+2.06%)
20-day average8.275 USD
50-day average8.192 USD
200-day average10.256 USD

Key support and resistance levels for BBOT

Derived from swing pivots over the last 200 sessions:

LevelTypeStrengthTouches
9.247 USDResistanceStrong3
9.47 USDResistanceModerate2
9.56 USDResistanceMinor1
LevelTypeStrengthTouches
8.535 USDSupportModerate2
8.08 USDSupportMinor1
7.98 USDSupportModerate2

BBOT 52-week range, momentum and volatility

52-week high14.87 USD (40.1% below)
52-week low7 USD (27.1% above)
14-day RSI63.2 (Bullish)
14-day ATR0.644 USD (7.23% of price, High volatility)

Related research pages

Frequently asked questions

Is BridgeBio Oncology Therapeutics (BBOT) in an uptrend or downtrend?

As of 2026-07-22, BBOT is in a range on the daily timeframe — moving averages not aligned / flat. Last close 8.9 USD vs 50-day average 8.192 USD and 200-day average 10.256 USD.

What are the key support and resistance levels for BBOT?

Nearest support is around 8.535 USD (moderate, 2 touches). Nearest resistance is around 9.247 USD (strong). Levels are derived from swing pivots over the last ~200 sessions.

What is BBOT's 52-week high and low?

Over the last 52 weeks, BBOT traded between 7 USD and 14.87 USD. It is currently 40.1% below its 52-week high.

Is BBOT overbought or oversold?

The 14-day RSI is 63.2 — in a neutral 30–70 range. Momentum reads as bullish.

How volatile is BBOT?

Its 14-day Average True Range is 0.644 (7.23% of price) — high volatility relative to price.